Publications by authors named "Roberto Sorio"

Claim this Profile
M
Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.
Maurizio Polano, Luca Bedon, Michele Dal Bo, Roberto Sorio, Michele Bartoletti

Clin Pharmacol Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer.
Michele Bartoletti, Giorgio Giorda, Alessandra Viel, Mara Fornasarig, Adrian Zdjelar, Roberto Sorio

Curr Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility-sparing treatment for serous borderline ovarian tumors with extra-ovarian invasive implants: Analysis from the MITO14 study database.
Francesca Falcone, Mario Malzoni, Marco Carnelli, Gennaro Cormio, Pierandrea De Iaco, Roberto Sorio

Gynecol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database.
Francesca Falcone, Enrico Breda, Gabriella Ferrandina, Mario Malzoni, Anna M Perrone, Roberto Sorio

Gynecol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives.
Alessandra Dall'Acqua, Michele Bartoletti, Nastaran Masoudi-Khoram, Roberto Sorio, Fabio Puglisi

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum-Sensitive Ovarian Cancer.
Sandro Pignata, Giovanni Scambia, Alessandro Villanucci, Emanuele Naglieri, Mikel Arruti Ibarbia, Roberto Sorio

Oncologist· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
Davide Viotto, Francesca Russo, Ilaria Anania, Ilenia Segatto, Gian Luca Rampioni Vinciguerra, Roberto Sorio

J Pathol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva.
Michele Bartoletti, Roberta Mazzeo, Marco De Scordilli, Anna Del Fabro, Maria Grazia Vitale, Roberto Sorio

Int J Gynecol Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer.
Sara Gagno, Michele Bartoletti, Chiara Romualdi, Elena Poletto, Simona Scalone, Roberto Sorio

Pharmacogenomics· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis.
Michele Bartoletti, Giacomo Pelizzari, Lorenzo Gerratana, Lucia Bortot, Davide Lombardi, Roberto Sorio

Int J Mol Sci· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer.
Sara Gagno, Elena Poletto, Michele Bartoletti, Luca Quartuccio, Chiara Romualdi, Roberto Sorio

Gynecol Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIMP-1 is Overexpressed and Secreted by Platinum Resistant Epithelial Ovarian Cancer Cells.
Maura Sonego, Evelina Poletto, Eliana Pivetta, Milena S Nicoloso, Rosanna Pellicani, Roberto Sorio

Cells· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Evolution of c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC).
Marica Garziera, Erika Cecchin, Giorgio Giorda, Roberto Sorio, Simona Scalone

Cells· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gennaro Daniele, Laura Arenare, Giovanni Scambia, Carmela Pisano, Roberto Sorio

Gynecol Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach.
Marica Garziera, Rossana Roncato, Marcella Montico, Elena De Mattia, Sara Gagno, Roberto Sorio

Cells· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study.
Bianca Posocco, Mauro Buzzo, Andrea Follegot, Luciana Giodini, Roberto Sorio

PLoS One· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Novel Somatic Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS).
Marica Garziera, Erika Cecchin, Vincenzo Canzonieri, Roberto Sorio, Giorgio Giorda

Int J Mol Sci· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.
Alessandra Dall'Acqua, Maura Sonego, Ilenia Pellizzari, Ilenia Pellarin, Vincenzo Canzonieri, Roberto Sorio

EMBO Mol Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.
Sandro Pignata, Giovanni Scambia, Alessandra Bologna, Simona Signoriello, Ignace B Vergote, Roberto Sorio

J Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells.
Maura Sonego, Ilenia Pellizzari, Alessandra Dall'Acqua, Eliana Pivetta, Ilaria Lorenzon, Roberto Sorio

Sci Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emesis and nausea related to single agent trabectedin in ovarian cancer patients: a sub-study of the MITO15 project.
Marilena Di Napoli, Chiara Della Pepa, Laura Arenare, Giovanni Scambia, Domenica Lorusso, Roberto Sorio

Support Care Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial.
Roberto Sorio, Célia Roemer-Becuwe, Felix Hilpert, Emma Gibbs, Yolanda García

Gynecol Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC.
Francesco Perrone, Gustavo Baldassarre, Stefano Indraccolo, Simona Signoriello, Gennaro Chiappetta, Roberto Sorio

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Marina Bagnoli, Silvana Canevari, Daniela Califano, Simona Losito, Massimo Di Maio, Roberto Sorio

Lancet Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-Analysis.
Marica Garziera, Marcella Montico, Ettore Bidoli, Simona Scalone, Roberto Sorio

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis